Active Funding Opportunities and Notices for NICHD
NICHD publishes and participates in various notices of funding opportunities (NOFOs) and NIH Guide Notices (NOTs) to support research and training activities.
NOTs and Active NOFOs for NICHD
Please note: the following are sorted by date, from most recent to older. Select a table heading to change how to sort the information.
| Number | Exp. Date | Activity Code(s) Sort ascending | Title |
|---|---|---|---|
| PAR-22-098 | December 10, 2024 | R21 | Global Brain and Nervous System Disorders Research Across the Lifespan (R21 Clinical Trial Optional) |
| PAR-24-046 | November 20, 2024 | R21 | Information and Practice Needs Relevant to Late Talking Children (R21 Clinical Trial Not Allowed) |
| PA-20-195 | January 8, 2025 | R21 | NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed) |
| PAR-22-101 | October 18, 2024 | R21 | Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed) |
| RFA-OD-22-007 | July 2, 2024 | R21 | INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Clinical Trial Readiness (R21 Clinical Trial Not Allowed) |
| NOT-OD-24-044 | February 14, 2025 | R21 | Notice of Special Interest (NOSI): Use of Digital Technology and Mobile Health (mHealth) to Improve Diagnosis, Assessments, Interventions, Management and Outcomes for Individuals with Down Syndrome Across the Lifespan (R21 Clinical Trial Not Allowed) |
| PAR-22-109 | May 8, 2025 | R21 | Dissemination and Implementation Research in Health (R21 Clinical Trial Optional) |
| PAR-23-296 | September 8, 2026 | R21 | Opportunities for HIV Cure Strategies at the Time of ART Initiation (R21 Clinical Trial Not Allowed) |
| NOT-OD-24-026 | July 16, 2024 | R21 | Notice of Special Interest (NOSI): Advance Data Science Approaches Through Secondary Data Analysis to Reveal Scientific Insights of COVID-19 Testing Technologies (R21) |
| RFA-EY-23-001 | June 16, 2026 | R21 | BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed) |
| PAR-23-294 | November 19, 2026 | R21 | Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) |
| PAR-24-045 | November 20, 2024 | R21 | Leveraging Extant Data to Understand Developmental Trajectories of Late Talking Children (R21 Clinical Trial Not Allowed) |
| PAR-23-299 | January 8, 2027 | R21 | Intervention Research to Improve Native American Health (R21 Clinical Trials Optional) |
| RFA-OD-23-013 | June 21, 2024 | R21 | Understanding Chronic Conditions Understudied Among Women (R21 Clinical Trial Optional) |
| NOT-OD-22-142 | March 17, 2025 | R21 | Notice of Special Interest (NOSI): Community-Based Participatory Research (CBPR) Initiative in Reducing and Eliminating Health Disparities with a focus on addressing diverse representation in research on Down syndrome (R21 Clinical Trial Optional) |
| PAR-23-131 | May 8, 2026 | R21 | Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional) |
| RFA-EB-22-002 | June 18, 2025 | R18 | HEAL Initiative: Translational Development of Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed) |
| RFA-NS-24-031 | January 29, 2027 | R18 | BRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation Technologies in the Human CNS (R18 - Clinical Trial Not Allowed) |
| PAR-24-145 | January 8, 2027 | R16 | Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed) |
| PAR-24-144 | January 8, 2027 | R16 | Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed) |
BACK TO TOP